» Articles » PMID: 39232875

Comparison of Pathologist and Artificial Intelligence-based Grading for Prediction of Metastatic Outcomes After Radical Prostatectomy

Abstract

Gleason grade group (GG) is the most powerful prognostic variable in localized prostate cancer; however, interobserver variability remains a challenge. Artificial intelligence algorithms applied to histopathologic images standardize grading, but most have been tested only for agreement with pathologist GG, without assessment of performance with respect to oncologic outcomes. We compared deep learning-based and pathologist-based GGs for an association with metastatic outcome in three surgical cohorts comprising 777 unique patients. A digitized whole slide image of the representative hematoxylin and eosin-stained slide of the dominant tumor nodule was assigned a GG by an artificial intelligence-based grading algorithm and was compared with the GG assigned by a contemporary pathologist or the original pathologist-assigned GG for the entire prostatectomy. Harrell's C-indices based on Cox models for time to metastasis were compared. In a combined analysis of all cohorts, the C-index for the artificial intelligence-assigned GG was 0.77 (95% confidence interval [CI]: 0.73-0.81), compared with 0.77 (95% CI: 0.73-0.81) for the pathologist-assigned GG. By comparison, the original pathologist-assigned GG for the entire case had a C-index of 0.78 (95% CI: 0.73-0.82). PATIENT SUMMARY: Artificial intelligence-enabled prostate cancer grading on a single slide was comparable with pathologist grading for predicting metastatic outcome in men treated by radical prostatectomy, enabling equal access to expert grading in lower resource settings.

References
1.
Bottke D, Golz R, Storkel S, Hinke A, Siegmann A, Hertle L . Phase 3 study of adjuvant radiotherapy versus wait and see in pT3 prostate cancer: impact of pathology review on analysis. Eur Urol. 2013; 64(2):193-8. DOI: 10.1016/j.eururo.2013.03.029. View

2.
Singhal N, Soni S, Bonthu S, Chattopadhyay N, Samanta P, Joshi U . A deep learning system for prostate cancer diagnosis and grading in whole slide images of core needle biopsies. Sci Rep. 2022; 12(1):3383. PMC: 8888647. DOI: 10.1038/s41598-022-07217-0. View

3.
Nagpal K, Foote D, Tan F, Liu Y, Chen P, Steiner D . Development and Validation of a Deep Learning Algorithm for Gleason Grading of Prostate Cancer From Biopsy Specimens. JAMA Oncol. 2020; 6(9):1372-1380. PMC: 7378872. DOI: 10.1001/jamaoncol.2020.2485. View

4.
Erak E, DePaula Oliveira L, Mendes A, Dairo O, Ertunc O, Kulac I . Predicting Prostate Cancer Molecular Subtype With Deep Learning on Histopathologic Images. Mod Pathol. 2023; 36(10):100247. PMC: 11225718. DOI: 10.1016/j.modpat.2023.100247. View

5.
Egevad L, Ahmad A, Algaba F, Berney D, Boccon-Gibod L, Comperat E . Standardization of Gleason grading among 337 European pathologists. Histopathology. 2012; 62(2):247-56. DOI: 10.1111/his.12008. View